Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Like its predecessor, “Wicked: For Good” more than doubles the runtime of Act II of the Broadway musical that inspired it. But unlike the first “Wicked” film, the sequel makes big additions to the ...

Recursion Pharmaceuticals remains a high-cash-burn, premium-valued biotech with unproven clinical success despite a recent 47% rally. RXRX's next 18 months are catalyst-rich, but key pipeline assets ...

Stress is part of everyday life, from work deadlines to family responsibilities. But when the tension does not fade—even when the stressor is gone—it may be a sign of something more serious. Jason ...

It can be easy to confuse the two, but there’s a difference, and it has to do with your internet speeds. Joe Supan is a senior writer for CNET covering home technology, broadband, and moving. Prior to ...

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – The REV102 program originated from a joint venture ...

While dementia and Alzheimer’s disease are terms that are often used interchangeably, they don’t mean the same thing. Understanding the difference isn’t just helpful for clarity, it’s essential for ...